Trials / Completed
CompletedNCT01020890
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms
A Cross-sectional Study on the Prevalence of GERD in Primary Care Patients With Upper GI Symptoms Using the GERD-Q. The Bulgarian GERD-Q Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,210 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide data on the gastroesophageal reflux disease (GERD) prevalence as percentage of patients with upper gastrointestinal (GI) symptoms that are identified with GERD using the Gerd-Q Questionnaire.
Conditions
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-11-26
- Last updated
- 2010-07-12
Locations
12 sites across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT01020890. Inclusion in this directory is not an endorsement.